Positron Emission Tomography-Positive Post-Chemotherapy Seminoma Masses: Time to Reevaluate the Role of Radiotherapy?

被引：1
|
作者：
Murthy, Vedang [1 ]
Johnny, Carlton [1 ]
Huddart, Robert [2 ,3 ]
机构：
[1] Tata Mem Hosp, Mumbai, Maharashtra, India
[2] Inst Canc Res, London, England
[3] Royal Marsden Hosp NHS, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 11期
关键词：
RESIDUAL MASS; CHEMOTHERAPY; TUMOR;
D O I：
10.1200/JCO.18.01991
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：937 / +
页数：3
相关论文
共 50 条
  • [1] Positron Emission Tomography-Positive Post-Chemotherapy Seminoma Masses: Time to Reevaluate the Role of Radiotherapy? Reply
    Cathomas, Richard
    Beyer, Jorg
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (11) : 938 - +
  • [2] Persistent positron emission tomography-positive liver lesions after successful chemotherapy in mediastinal seminoma
    Holdhoff, Matthias
    Wung, Peter K.
    Petronis, John D.
    Couzi, Rima
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (17) : 2482 - 2484
  • [3] The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma
    Hinz, S.
    De Wit, M.
    Kempkensteffen, C.
    Christoph, F.
    Miller, K.
    Schostak, M.
    Krege, S.
    Kliesch, S.
    Bares, R.
    Brenner, W.
    Franzius, C.
    Schrader, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 84 - 84
  • [4] The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma
    Hinz, Stefan
    Schrader, Mark
    Kempkensteffen, Carsten
    Bares, Roland
    Brenner, Winfried
    Krege, Susanne
    Franzius, Christiane
    Kliesch, Sabine
    Heicappel, Ruediger
    Miller, Kurt
    de Wit, Maike
    JOURNAL OF UROLOGY, 2008, 179 (03): : 936 - 940
  • [5] Management of post-chemotherapy residual masses in advanced seminoma
    Fléchon, A
    Bompas, E
    Biron, P
    Droz, JP
    JOURNAL OF UROLOGY, 2002, 168 (05): : 1975 - 1979
  • [6] False Positive 2-18Fluroro-deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients With Disseminated Seminoma and Post-Chemotherapy Residual Masses
    Wagner, Mathilde
    Bellmunt, Joaquim
    Boutros, Celine
    Bonardel, Gerald
    Loriot, Yohann
    Albiges, Laurence
    Massard, Christophe
    Fizazi, Karim
    CLINICAL GENITOURINARY CANCER, 2013, 11 (01) : 66 - 69
  • [7] Radiotherapy for Post-Chemotherapy Residual Mass in Advanced Seminoma: A Fluorodeoxyglucose Positron Emission Tomography- Computed Tomography-Based Risk-adapted Approach
    Murthy, V.
    Karmakar, S.
    Carlton, J.
    Joshi, A.
    Krishnatry, R.
    Prabhash, K.
    Noronha, V.
    Bakshi, G.
    Prakash, G.
    Pal, M.
    Menon, S.
    Agrawal, A.
    Rangarajan, V.
    CLINICAL ONCOLOGY, 2021, 33 (07) : e315 - e321
  • [8] The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma - Comment
    Gonzalgo, Mark L.
    JOURNAL OF UROLOGY, 2008, 179 (03): : 940 - 940
  • [9] Re: The Role of Positron Emission Tomography in the Evaluation of Residual Masses After Chemotherapy for Advanced Stage Seminoma Reply
    Hinz, S.
    Schrader, M.
    Kempkensteffen, C.
    Bares, R.
    Brenner, W.
    Krege, S.
    Franzius, C.
    Kliesch, S.
    Heicappel, R.
    Miller, K.
    de Wit, M.
    JOURNAL OF UROLOGY, 2008, 180 (06): : 2718 - 2718
  • [10] Positron emission tomography scans in the evaluation of post-chemotherapy residual masses in patients with metastatic testicular tumors: A prospective study
    Thyavihally, Yuvaraja B.
    Sengar, Manju
    Rangarajan, Venkatesh
    Tongaonkar, Hemant B.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 269 - 269
12345